The 50 lots containing the 12 million doses with the shorter expiration periods should be used by Feb. 15, 2010, to ensure that the vaccine is used while it remains within its potency specification. There are no safety concerns with these lots of 2009 H1N1 vaccine, according to the alert.
All pre-filled syringes that have not been used by Feb. 15, 2010, should be discarded in an appropriate manner, or you may return the product for destruction to Sanofi Pasteur.
See a full list of the affected lots.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.